Mifegymiso abortion pills to be available this fallCelopharma issues update on risk minimization strategies, including a restrictive distribution and administration program. Ditching the tampon: Some women seeking reusable period careSome millennials choosing environmentally friendly forms of feminine products. Air pollution: Bad for the heart, bad for the fetus New studies provide more data on adverse effects of particulate matter Oral contraceptives vary in risk of pulmonary embolism, stroke and myocardial infarction Levonorgestrel safer than desogestrel, and 20 µg estrogen safer than 30–40 µg. New Canadian guidelines for prevention and treatment of Zika virus infection Include recommendations for travel, preventing sexual transmission and patient evaluation. 5 reasons your patient is not getting pregnant Endocrine Society takes strong stance against custom-compounded bioidentical hormone products No rationale for routine prescribing of these unregulated, untested, potentially harmful products. New Canadian clinical guidelines on using intrauterine contraception Review safety and efficacy of copper IUDs and levonorgestrel intrauterine systems. A viewpoint on pharmacist prescribing of oral contraceptives in the United States Intended to decrease barriers to contraceptive access, and reduce costs and unintended pregnancies. Does vitamin D status in pregnancy affect multiple sclerosis risk in offspring? Finnish study suggests insufficient maternal vitamin D may increase MS risk in children. First Previous 28 29 30 31 32 Next Last
